Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- ELife: Structure of METTL3-METTL14 with an m6A nucleotide reveals insights into m6A conversion and sensing (Rao, Gupta, et al)
- Kurmasheva Lab is Featured in CPRIT Annual Report
- Cell: Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation (Gupta Lab)
- International Journal of Molecular Sciences: Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination Therapy (Penalva)
- Luiz Penalva, PhD, to Receive “The Cure Starts Here” Grant.
Events
Greehey CCRI Seminar Series: Katsumi Kitagawa, Pharm.D., PhD (UTHSA)
Presentation Title: “Chromosome Instability in Ewing Sarcoma.”
Greehey CCRI Seminar Series: Benjamin Stanton, PhD (Nationwide Children’s)
Presentation Title: Systems Epigenetics of Childhood Cancer”
Greehey CCRI Seminar Series: Kate Lawrenson, PhD (UTHSA, Department of Obstetrics & Gynecology)
Presentation title: TBD